New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Top of the News-dtet
Generalizing Genomics Learning
A new NIH network aims to remove barriers and share knowledge to drive more widespread adoption of genomics in clinical settings
Lost Ground: Cancer Screening in the COVID-19 Era
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.
Genomics May Predict Cancer Treatment Side Effects
...
Already a member? Log in here
Survey Finds Soft Skills Sought in Hiring New Pathologists
...
Already a member? Log in here
Trump Budget Proposes Steep NIH Cuts, Hike to FDA User Fees
...
Already a member? Log in here
Dx Investments Hold Steady in 2016, Number of Exits Declines
...
Already a member? Log in here
2016 Investments Steady, Exits Decline
From - Diagnostic Testing & Emerging Technologies
Investments in the diagnostics and tools (Dx/Tools) sector remained steady in 2016, according to Silicon Valley Bank's annual report…
FDA Watch: New FDA Approvals & Applications in Diagnostics
...
Already a member? Log in here
Sequencing Not Ready for First-Line, Newborn Screening
...
Already a member? Log in here
CDRH Emphasizes Biomarkers and Precision Diagnostics in 2017 Priorities
...
Already a member? Log in here
Quest Diagnostics Leads Personalized Medicine Developments
...
Already a member? Log in here